Role of extracorporeal lung assist in the treatment of acute respiratory failure

Minerva Anestesiologica

Volumn 72, Issue 6, 2006, Pages 587-595

  Kopp, R ^a   Dembinski, R ^a   Kuhlen, R ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Adult; Extracorporeal assist; Membrane lung; Respiratory distress syndome

Indexed keywords

ACUTE RESPIRATORY FAILURE; ALGORITHM; ARTICLE; ARTIFICIAL MEMBRANE; ARTIFICIAL VENTILATION; BLOOD PUMP; CAVA VEIN; CHRONIC RESPIRATORY FAILURE; CLINICAL TRIAL; EXTRACORPOREAL OXYGENATION; HUMAN; HYPOXEMIA; LUNG GAS EXCHANGE; LUNG RESISTANCE; MORTALITY; OXYGENATOR; PROCESS OPTIMIZATION; RESPIRATORY AIRFLOW; SAFETY; SEVERE ACUTE RESPIRATORY SYNDROME; SURVIVAL RATE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VENOUS CIRCULATION;

ACUTE DISEASE; ALGORITHMS; EQUIPMENT DESIGN; EXTRACORPOREAL MEMBRANE OXYGENATION; HUMANS; RESPIRATORY INSUFFICIENCY;

EID: 33745278085     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-24.
2. MacCallum NS, Evans TW. Epidemiology of acute lung injury. Curr Opin Crit Care 2005;11:43-9.
3. Kopp R, Kuhlen R, Max M, Rossaint R. Evidence-based medicine in the therapy of the acute respiratory distress syndrome. Intensive Care Med 2002;28:244-55.
4. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301-8.
5. Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004;351:327-36.
6. Lewandowski K, Rossaint R, Pappert D, Gerlach H, Slama KJ, Weidemann H et al. High survival rate in 122 ARDS patients managed according to a clinical algorithm including extracorporeal membrane oxygenation. Intensive Care Med 1997;23:819-35.
7. Mols G, Loop T, Geiger K, Farthmann E, Benzing A. Extracorporeal membrane oxygenation: a ten-year experience. Am J Surg 2000;180:144-54.
8. Henzler D, Dembinski R, Kopp R, Hawickhorst R, Rossaint R, Kuhlen R. [Treatment of acute respiratory distress syndrome in a treatment center. Success is dependent on risk factors] Anaesthesist 2004;53:235-43. German.
9. Hemmila MR, Rowe SA, Boules TN, Miskulin J, McGillicuddy JW, Schuerer D et al. Extracorporeal life support for severe acute respiratory distress syndrome in adults. Ann Surg 2004;240:595-605; discussion 605-7.
10. Linden V, Palmer K, Reinhard J, Westman R, Ehren H, Granholm T, Frenckner B. High survival in adult patients with acute respiratory distress syndrome treated by extracorporeal membrane oxygenation, minimal sedation, and pressure supported ventilation. Intensive Care Med 2000;26:1630-7.
11. Peek GJ, Moore HM, Moore N, Sosnowski AW, Firmin RK. Extracorporeal membrane oxygenation for adult respiratory failure. Chest 1997;112:759-64.
12. Ullrich R, Lorber C, Roder G, Urak G, Faryniak B, Sladen RN et al. Controlled airway pressure therapy, nitric oxide inhalation, prone position, and extracorporeal membrane oxygenation (ECMO) as components of an integrated approach to ARDS. Anesthesiology 1999;91:1577-86.
13. Hill JD, O'Brien TG, Murray JJ. Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). N Engl J Med 1972;28 629-34.
14. van Oeveren W, Kazatchkine MD, Descamps-Latscha B, Maillet F, Fischer E, Carpentier A et al. Deleterious effects of cardiopulmonary bypass A prospective study of bubble versus membrane oxygenation. J Thorac Cardiovasc Surg 1985;89:888-99.
15. Zapol WM, Snider MT, Hill JD, Fallat RJ, Bartlett RH, Edmunds LH et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 1979;242:2193-6.
16. 2 removal in severe acute respiratory failure. JAMA 198; 256:881-6.
17. 2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med 1994; 149:295-305.
18. UK-Collaborative ECMO Trial Group. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. Lancet 1996;348:75-82.
19. Petrou S, Edwards L. Cost effectiveness analysis of neonatal extracorporeal membrane oxygenation based on four year results from the UK Collaborative ECMO Trial. Arch Dis Child Fetal Neonatal Ed 2004;89: F263-8.
20. CESAR Trial Group. Conventional Ventilation or ECMO for Severe Adult Respiratory Failure - CESAR Trial. http://www.cesar-trial.arg/
21. Foley DS, Pranikoff T, Younger JG, Swaniker F, Hemmila MR, Remenapp RA et al. A review of 100 patients transported on extracorporeal life support. ASAIO J 2002;48:612-9.
22. Rossaint R, Pappert D, Gerlach H, Lewandowski K, Keh D, Falke K. Extracorporeal membrane oxygenation for transport of hypoxaemic patients with severe ARDS. Br J Anaesth 1997;78:241-6.
23. Bindslev L, Eklund J, Norlander O, Swedenborg J, Olsson P, Nilsson E et al. Treatment of acut respiratory failure by extracorporeal carbon dioxide elimination performed with a surface heparinized artificial lung. Anesthesiology 1987;67:117-20.
24. Wendel HP, Ziemer G. Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation. Eur J Cardiothorac Surg 1999;16:342-50.
25. Peek GJ, Killer HM, Sosnowski MA, Firmin RK. Modular extracorporeal life support for multiorgan failure patients. Liver 2002;22 Suppl 2:69-71.
26. Kozek-Langenecker SA. Anticoagulation with prostaglandins during extracorporeal circulation. Wien Klin Wochenschr 1999;111:129-40.
27. Johnston N, Wait M, Huber L. Argatroban in adult extra-corporeal membrane oxygenation. J Extra Corpor Technol 2002;34:281-4.
28. Dager WE, Gosselin RC, Yoshikawa R, Owings JT. Lepirudin in heparin-induced thrombocytopenia and extracorporeal membranous oxygenation. Ann Pharmacother 2004;38:598-601.
29. Montoya JP, Shanley CJ, Merz SI, Bartlett RH. Plasma leakage through microporous membranes. Role of phospholipids. ASAIO J 1992;38:M399-M405.
30. Eash HJ, Jones HM, Hattler BG, Federspiel WJ. Evaluation of plasma resistant hollow fiber membranes for artificial lungs. ASAIO J 2004;50:491-7.
31. Peek GJ, Killer HM, Reeves R, Sosnowski AW, Firmin RK. Early experience with a polymethyl pentene oxygenator for adult extracorporeal life support. ASAIO J 2002;48:480-2.
32. Gobel C, Arvand A, Eilers R, Marseille O, Bals C, Meyns B et al. Development of the MEDOS/HIA DeltaStream extracorporeal rotary blood pump. Artif Organs 2001;25:358-65.
33. Christiansen S, Gobel C, Buhre W, Reul H, Autschbach R. Successful use of a miniaturized bypass system with the DeltaStream extracorporeal rotary blood pump. J Thorac Cardiovasc Surg 2003;125:43-4.
34. Dembinski R, Kopp R, Henzler D, Hochhausen N, Oslender N, Max M et al. Extracorporeal gas exchange with the Deltastream rotary blood pump in experimental lung injury. Artif Organs 2003;27:530-6.
35. Segers PA, Heida JF, de Vries I, Maas C, Boogaart AJ, Eilander S. Clinical evaluation of nine hollow-fibre membrane oxygenators. Perfusion 2001;16:95-106.
36. Conrad SA, Brown EG, Grier LR, Baier J, Blount J, Heming T et al. Arteriovenous extracorporeal carbon dioxide removal: a mathematical model and experimental evaluation. ASAIO J 1998;44:267-77.
37. Frank BR, Tao W, Brunston RL Jr, Alpard SK, Bidani A, Zwischenberger JB. High flow/low resistance cannulas for percutaneous arteriovenous carbon dioxide removal. ASAIO J 1997;43:M817-M820.
38. Jayroe JB, Wang D, Deyo DJ, Alpard SK, Bidani A, Zwischenberger JB. The effect of augmented hemodynamics on blood flow during arteriovenous carbon dioxide removal. ASAIO J 2003;49:30-4.
39. Reng M, Philipp A, Kaiser M, Pfeifer M, Gruene S, Schoelmerich J. Pumpless extracorporeal lung assist and adult respiratory distress syndrome. Lancet 2000;356:219-20.
40. Conrad SA, Zwischenberger JB, Grier LR, Alpard SK, Bidani A. Total extracorporeal arteriovenous carbon dioxide removal in acute respiratory failure: a phase I clinical study. Intensive Care Med 2001;27:1340-51.
41. Bein T, Prasser C, Philipp A, Muller T, Weber F, Schlitt HJ et al. [Pumpless extracorporeal lung assist using arterio-venous shunt in severe ARDSExperience with 30 cases]. Anaesthesist 2004;53:813-9. German.
42. Bein T, Scherer MN, Philipp A, Weber F, Woertgen C. Pumpless extracorporeal lung assist (pECLA) in patients with acute respiratory distress syndrome and severe brain injury. J Trauma 2005;58:1294-7.
43. Cattaneo G, Strauss A, Reul H. Compact intra- and extracorporeal oxygenator developments. Perfusion 2004;19:251-5.
44. Conrad SA, Eggerstedt JM, Grier LR, Morris VF, Romero MD. Intravenacaval membrane oxygenation and carbon dioxide removal in severe acute respiratory failure. Chest 1995;107:1689-97.
45. Zwischenberger JB, Anderson CM, Cook KE, Lick SD, Mockros LF, Bartlett RH. Development of an implantable artificial lung: challenges and progress. ASAIO J 2001;47:316-20.
46. Lynch WR, Montoya JP, Brant DO, Schreiner RJ, Iannettoni MD, Bartlett RH. Hemodynamic effect of a low-resistance artificial lung in series with the native lungs of sheep. Ann Thorac Surg 2000;69:351-6.
47. Zwischenberger JB, Wang D, Lick SD, Deyo DJ, Alpard SK, Chambers SD. The paracorporeal artificial lung improves 5-day outcomes from lethal smoke/ burn-induced acute respiratory distress syndrome in sheep. Ann Thorac Surg 2002;74:1011-6.